Business

Medicure Announces Upcoming Conference Presentations

Medicure Announces Upcoming Conference Presentations Medicure Announces Upcoming C...

articleMedicure Inc.April 5, 20164/company/medicure-inc/news/medicure-announces-upcoming-conference-presentations
Medicure Announces Upcoming Conference Presentations

About this update from Medicure Inc.

[{"type":"text","content":"\n\n\n\nMedicure Announces Upcoming Conference Presentations\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMedicure Announces Upcoming Conference Presentations\nCanada NewsWire\nWINNIPEG, April 5, 2016\n\n\n\nWINNIPEG, April 5, 2016 /CNW/ - Medicure Inc. (\"Medicure\") (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, will be participating and presenting at the following investor conferences in April and May, 2016;\n\n\nApril 7th at the Laurentian Bank Securities Annual Institutional Investor Conference at the Sofitel Hotel, Montreal. Medicure's CEO and Chairman, Albert Friesen, will participate in a healthcare panel entitled \"Specialty Pharmaceuticals - Continuing Success in Challenging Markets\". The panel runs 1:35 PM – 3:00 PM.\n\n\nApril 11th - 12th at The MicroCap Conference at the Hilton Toronto. Medicure's President and COO, Dawson Reimer, will present a corporate update at 2:30 PM on April 12th.\n\n\nMay 2nd – 3rd at the Bloom Burton & Co Healthcare Investor Conference at the Sheraton Centre Toronto Hotel. Medicure's President and COO, Dawson Reimer, will present a corporate update at 11:30 AM on May 3rd.\n\nAbout Medicure Inc.\n\nMedicure is a specialty pharmaceutical company focused on the development and commercialization of therapeutics for the U.S. hospital market.  The primary focus of the Company and its subsidiaries is the marketing and distribution of AGGRASTAT (tirofiban HCl) for non-ST elevation acute coronary syndrome in the United States, where it is sold through the Company's U.S. subsidiary, Medicure Pharma, Inc.  For more information on Medicure please visit www.medicure.com.\nSOURCE Medicure Inc.\n\n\n\n\n\n\n2-1250 Waverley Street, Winnipeg, Manitoba, Canada R3T 6C6, Phone: 204-487-7412, Fax: 204-488-9823Copyright CNW Group 2016","length":3431,"tagName":"div"}]

More updates from Medicure Inc.